Publicaciones en colaboración con investigadores/as de Hospital General Universitario Gregorio Marañón (26)

2023

  1. Optimizing subjective wellbeing with amisulpride in first episode schizophrenia or related disorders

    Psychological Medicine, Vol. 53, Núm. 13, pp. 5986-5991

  2. Tobacco use in first-episode psychosis, a multinational EU-GEI study

    Psychological Medicine, Vol. 53, Núm. 15, pp. 7265-7276

2022

  1. The network structure of cognitive deficits in first episode psychosis patients

    Schizophrenia Research, Vol. 244, pp. 46-54

2021

  1. Impact of previous tobacco use with or without cannabis on first psychotic experiences in patients with first-episode psychosis

    Schizophrenia Research, Vol. 236, pp. 19-28

  2. Premorbid Characteristics as Predictors of Early Onset Versus Adult Onset in Patients with a First Episode of Psychosis

    Journal of Clinical Psychiatry, Vol. 82, Núm. 6

2020

  1. Personalized medicine begins with the phenotype: identifying antipsychotic response phenotypes in a first-episode psychosis cohort

    Acta Psychiatrica Scandinavica, Vol. 141, Núm. 6, pp. 541-552

2019

  1. Gene-environment interaction between an endocannabinoid system genetic polymorphism and cannabis use in first episode of psychosis

    European Neuropsychopharmacology, Vol. 29, Núm. 6, pp. 786-794

  2. Influence of social cognition as a mediator between cognitive reserve and psychosocial functioning in patients with first episode psychosis

    Psychological Medicine

2018

  1. Factors associated with poor functional outcome in bipolar disorder: sociodemographic, clinical, and neurocognitive variables

    Acta Psychiatrica Scandinavica, Vol. 138, Núm. 2, pp. 145-154

  2. Individual trajectories of cognitive performance in first episode psychosis: a 2-year follow-up study

    European Archives of Psychiatry and Clinical Neuroscience, Vol. 268, Núm. 7, pp. 699-711

  3. Smoking does not impact social and non-social cognition in patients with first episode psychosis

    Schizophrenia Research, Vol. 199, pp. 64-74

2017

  1. Persistent negative symptoms in first-episode psychosis: Early cognitive and social functioning correlates and differences between early and adult onset

    Journal of Clinical Psychiatry, Vol. 78, Núm. 9, pp. 1414-1422

2016

  1. Effects of functional remediation on neurocognitively impaired bipolar patients: Enhancement of verbal memory

    Psychological Medicine, Vol. 46, Núm. 2, pp. 291-301

  2. Functional remediation in bipolar disorder: 1-year follow-up of neurocognitive and functional outcome

    British Journal of Psychiatry, Vol. 208, Núm. 1, pp. 87-93

  3. Opposite cannabis-cognition associations in psychotic patients depending on family history

    PLoS ONE, Vol. 11, Núm. 8

  4. Validation of the 'Test of the Adherence to Inhalers' (TAI) for Asthma and COPD Patients

    Journal of Aerosol Medicine and Pulmonary Drug Delivery, Vol. 29, Núm. 2, pp. 142-152

2015

  1. Functional remediation for patients with bipolar II disorder: Improvement of functioning and subsyndromal symptoms

    European Neuropsychopharmacology, Vol. 25, Núm. 2, pp. 257-264

  2. Intensive care practices in brain death diagnosis and organ donation

    Anaesthesia, Vol. 70, Núm. 10, pp. 1130-1139

  3. Premorbid adjustment and clinical correlates of cognitive impairment in first-episode psychosis: The PEPsCog Study

    Schizophrenia Research, Vol. 164, Núm. 1-3, pp. 65-73

2014

  1. Desarrollo de la versión española de la Escala Breve para la Evaluación de la Capacidad Funcional [Sp-UPSA-Brief] para pacientes con esquizofrenia y trastorno bipolar

    Revista de Psiquiatria y Salud Mental, Vol. 7, Núm. 3, pp. 113-120